Moreover, the anti-proliferative effects of pterostilbene via Ki-67 down-regulation have been demonstrated by immunohistochemistry staining on other types of cancers via in vivo studies such as skin melanoma, prostate cancer, and hepatocellular carcinoma18, 50, 51. Here, MKI67 is linked to prostate cancer.